Sulfonylurea and neuroprotection: The bright side of the moon

• Main Authors: Nawar R Hussien (Author), Marwa S Al-Naimi (Author), Huda A Rasheed (Author), Hayder M Al-kuraishy (Author), Ali I Al-Gareeb (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2018-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Sulfonylurea (SUR) agents are the second and most used oral hypoglycemic drugs after metformin and they still as an imperative tool for most favorable of glucose control. SURs are used mainly in the management of Type 2 diabetes mellitus since; they are effective in the glycemic control and reductio...